Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

Part of paid clinical trials in Huntington Beach, California.

Sponsor
Aerie Pharmaceuticals
Study ID
NCT03808688
Phase
PHASE4
Status
Completed

Conditions

  • Glaucoma, Open-Angle
  • Ocular Hypertension

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

To evaluate the IOP lowering efficacy of netarsudil ophthalmic solution 0.02% when used as monotherapy or when used concomitantly with other IOP-lowering agents in subjects with elevated IOP due to open angle glaucoma or ocular hypertension in a real-world clinical setting. The study is an open-label design. The patients will receive treatment for 12 weeks.

Key Dates

Start date
Dec 27, 2018
Status verified
Nov 2019
Primary completion
Jul 26, 2019
Completion
Jul 26, 2019

Study Design

Enrollment
261 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Netarsudil Ophthalmic Solution 0.02%

Primary Outcome Measure

Intraocular Pressure (IOP) [ Time Frame: 12 weeks ]

Locations (22)

FacilityCityStateZIPSite coordinators
Atlantis EyecareHuntington BeachCalifornia92647-
Harvard Eye AssociatesLaguna HillsCalifornia92653-
North Bay Eye Associates, IncPetalumaCalifornia94954-
Shettle Eye Research IncLargoFlorida33773-
Center For SightSarasotaFlorida34238-
Coastal Research Associates, LLCRoswellGeorgia30076-
Wheaton Eye Clinic, LtdWheatonIllinois60187-
Stiles Eyecare Excellence and Glaucoma Institute, PAOverland ParkKansas66213-
Gaddie Eye Centers, LLCLouisvilleKentucky40241-
Glaucoma ConsultantsBaltimoreMaryland21204-
Tekwani Vision CenterSt LouisMissouri63128-
Mark J. Weiss, M.D., Inc.TulsaOklahoma74104-
Scott & Christie and Associates, PCCranberry TownshipPennsylvania16066-
Valley Eye Professionals, LLCHuntingdon ValleyPennsylvania19006-
Carolina Cataract & Laser CenterLadsonSouth Carolina29456-
Total Eye Care, PAMemphisTennessee38119-
VRF Eye Specialty GroupMemphisTennessee38120-
Advancing Vision ResearchNashvilleTennessee37204-
Keystone ResearchAustinTexas78731-
Cataract & Glaucoma CenterEl PasoTexas79902-
Houston Eye AssociatesHoustonTexas77025-
The Eye Centers of Racine and KenoshaRacineWisconsin53405-

Find similar trials in Huntington Beach, CA

Related Studies